NautaDutilh assisted medical technology company ONWARD Medical with obtaining an up to EUR 52.5 million secured debt financing from Runway Growth Capital LLC.
In addition, ONWARD Medical issued warrants which will entitle Runway Growth Capital LLC to purchase ordinary shares in the capital of Onward Medical.
“ONWARD Medical aims to make significant improvement in the lives of patients with spinal cord injuries. By assisting them with this EUR 52.5 million in debt financing we have contributed to their mission and hopefully these patients are one step closer to a more normal and comfortable life”
Our firm acted alongside Skadden and Bär & Karrer. Paul van der Bijl (Corporate M&A, Partner) led the team, which further consisted of Jinne van Belle (Finance, Partner), Huub Verschoor (Finance, Senior Associate), Eline van Marle (Corporate M&A, Associate) and Daan Hagelstein (Corporate M&A, Senior Associate).
About ONWARD Medical
ONWARD Medical creates innovative spinal cord stimulation therapies to restore movement, function, and independence in people with spinal cord injury (SCI) and movement disorders. ONWARD Medical is listed on Euronext Brussels and Euronext Amsterdam.